All Stories

  1. Aggressive B cell lymphomas retain ATR-dependent determinants of T cell exclusion from the germinal center dark zone

    Article • Journal of Clinical Investigation, July 2025, American Society for Clinical Investigation

    Claudio Tripodo

  2. PatternExtract: A facile, scalable pipeline for point pattern generation from spatial imaging data

    Article • June 2025, Cold Spring Harbor Laboratory Press

    Claudio Tripodo

  3. A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements

    Article • Science, August 2024, American Association for the Advancement of Science

    Claudio Tripodo

  4. Unsupervised representation learning of chromatin images identifies changes in cell state and tissue organization in DCIS

    Article • Nature Communications, July 2024, Springer Science + Business Media

    Claudio Tripodo

  5. Iron capture through CD71 drives perinatal and tumor-associated Treg expansion

    Article • JCI Insight, July 2024, American Society for Clinical Investigation

    Claudio Tripodo

  6. ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization

    Article • Arteriosclerosis Thrombosis and Vascular Biology, May 2024, Wolters Kluwer Health

    Claudio Tripodo

  7. Combined therapy targeting AR and EZH2 curbs castration-resistant prostate cancer enhancing anti-tumor T-cell response

    Article • Epigenomics, March 2024, Taylor & Francis

    Claudio Tripodo

  8. Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study

    Article • Haematologica, March 2024, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  9. Spatially-resolved transcriptomics reveal macrophage heterogeneity and prognostic significance in diffuse large B-cell lymphoma

    Article • Nature Communications, March 2024, Springer Science + Business Media

    Claudio Tripodo

  10. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer

    Article • EBioMedicine, March 2024, Elsevier

    Claudio Tripodo

  11. Neutrophils Mediate Protection Against Colitis and Carcinogenesis by Controlling Bacterial Invasion and IL22 Production by γδ T Cells

    Article • Cancer Immunology Research, February 2024, American Association for Cancer Research (AACR)

    Claudio Tripodo

  12. ZEB1 shapes AML immunological niches, suppressing CD8 T cell activity while fostering Th17 cell expansion

    Article • Cell Reports, February 2024, Elsevier

    Claudio Tripodo

  13. Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer

    Article • Cell Death and Disease, January 2024, Springer Science + Business Media

    Claudio Tripodo

  14. EMID2 is a novel biotherapeutic for aggressive cancers identified by in vivo screening

    Article • Journal of Experimental & Clinical Cancer Research, January 2024, Springer Science + Business Media

    Claudio Tripodo

  15. Impaired activation of plasmacytoid dendritic cells via toll-like receptor 7/9 and STING is mediated by melanoma-derived immunosuppressive cytokines and metabolic drift

    Article • Frontiers in Immunology, January 2024, Frontiers

    Claudio Tripodo

  16. Resampling approaches for the quantitative analysis of spatially distributed cells

    Article • Data Intelligence, January 2024, China Science Publishing & Media Ltd.

    Claudio Tripodo

  17. Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth

    Article • Nature Communications, November 2023, Springer Science + Business Media

    Claudio Tripodo

  18. Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth

    Article • Nature Communications, October 2023, Springer Science + Business Media

    Claudio Tripodo

  19. Fasting mimicking diet in mice delays cancer growth and reduces immunotherapy-associated cardiovascular and systemic side effects

    Article • Nature Communications, September 2023, Springer Science + Business Media

    Claudio Tripodo

  20. Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle

    Article • Frontiers in Immunology, August 2023, Frontiers

    Claudio Tripodo

  21. No Clear Clustering Dysbiosis from Salivary Microbiota Analysis by Long Sequencing Reads in Patients Affected by Oral Squamous Cell Carcinoma: A Single Center Study

    Article • Cancers, August 2023, MDPI AG

    Claudio Tripodo

  22. A three-gene signature marks the time to locoregional recurrence in luminal-like breast cancer

    Article • ESMO Open, August 2023, Elsevier

    Claudio Tripodo

  23. hMENA isoforms regulate cancer intrinsic type I IFN signaling and extrinsic mechanisms of resistance to immune checkpoint blockade in NSCLC

    Article • Journal for ImmunoTherapy of Cancer, August 2023, BMJ

    Claudio Tripodo

  24. A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia

    Article • Cell Reports, August 2023, Elsevier

    Claudio Tripodo

  25. Rewiring innate and adaptive immunity with TLR9 agonist to treat osteosarcoma

    Article • Journal of Experimental & Clinical Cancer Research, June 2023, Springer Science + Business Media

    Claudio Tripodo

  26. Inhibition of FGF23 is a therapeutic strategy to target hematopoietic stem cell niche defects in β-thalassemia

    Article • Science Translational Medicine, May 2023, American Association for the Advancement of Science

    Claudio Tripodo

  27. Programmed cell death 1 genetic variant and liver damage in nonalcoholic fatty liver disease

    Article • Liver International, April 2023, Wiley

    Sami Qadri, Claudio Tripodo

  28. Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma

    Article • Cancer Discovery, April 2023, American Association for Cancer Research (AACR)

    Claudio Tripodo

  29. Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle

    Article • April 2023, Cold Spring Harbor Laboratory Press

    Claudio Tripodo

  30. Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model

    Article • Cell Death Discovery, April 2023, Springer Science + Business Media

    Claudio Tripodo

  31. Data from Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

    Article • March 2023, American Association for Cancer Research (AACR)

    Claudio Tripodo

  32. Data from Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

    Article • March 2023, American Association for Cancer Research (AACR)

    Claudio Tripodo

  33. Supplementary Data from Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

    Article • March 2023, American Association for Cancer Research (AACR)

    Claudio Tripodo

  34. Supplementary Data from Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

    Article • March 2023, American Association for Cancer Research (AACR)

    Claudio Tripodo

  35. Supplementary Data from Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

    Article • March 2023, American Association for Cancer Research (AACR)

    Claudio Tripodo

  36. Supplementary Data from Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

    Article • March 2023, American Association for Cancer Research (AACR)

    Claudio Tripodo

  37. SARS-CoV-2 infection induces DNA damage, through CHK1 degradation and impaired 53BP1 recruitment, and cellular senescence

    Article • Nature Cell Biology, March 2023, Springer Science + Business Media

    Claudio Tripodo

  38. Author Correction: Tissue fluidification promotes a cGAS–STING cytosolic DNA response in invasive breast cancer

    Article • Nature Materials, January 2023, Springer Science + Business Media

    Claudio Tripodo

  39. A planar-polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia

    Article • January 2023, Cold Spring Harbor Laboratory Press

    Claudio Tripodo

  40. CK2β-regulated signaling controls B cell differentiation and function

    Article • Frontiers in Immunology, January 2023, Frontiers

    Claudio Tripodo

  41. Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance

    Article • Cancer Cell, January 2023, Elsevier

    Claudio Tripodo

  42. Tissue fluidification promotes a cGAS–STING cytosolic DNA response in invasive breast cancer

    Article • Nature Materials, December 2022, Springer Science + Business Media

    Professor Roberto Cerbino, Claudio Tripodo

  43. Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling

    Article • Molecular Cancer, December 2022, Springer Science + Business Media

    Claudio Tripodo

  44. Salivary Microbiota Composition in Patients with Oral Squamous Cell Carcinoma: A Systematic Review

    Article • Cancers, November 2022, MDPI AG

    Claudio Tripodo

  45. MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

    Article • Blood Advances, October 2022, American Society of Hematology

    Claudio Tripodo

  46. Identification of an effective chemotherapy and DNA damage response inhibitor combination for diffuse large b cell lymphoma

    Article • European Journal of Cancer, October 2022, Elsevier

    Claudio Tripodo

  47. Publisher Correction: Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma

    Article • Nature Materials, September 2022, Springer Science + Business Media

    Claudio Tripodo

  48. Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects

    Article • Cell Reports, August 2022, Elsevier

    Claudio Tripodo

  49. Stromal and Immune Cell Dynamics in Tumor Associated Tertiary Lymphoid Structures and Anti-Tumor Immune Responses

    Article • Frontiers in Cell and Developmental Biology, July 2022, Frontiers

    Claudio Tripodo

  50. Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models

    Article • Biomedicine & Pharmacotherapy, July 2022, Elsevier

    Claudio Tripodo

  51. YAP/TAZ activity in stromal cells prevents ageing by controlling cGAS–STING

    Article • Nature, June 2022, Springer Science + Business Media

    Claudio Tripodo

  52. Spatial transcriptome of a germinal center plasmablastic burst hints at MYD88 / CD79B mutants‐enriched diffuse large B‐cell lymphomas

    Article • European Journal of Immunology, May 2022, Wiley

    Claudio Tripodo

  53. Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation

    Article • eLife, April 2022, eLife

    Claudio Tripodo

  54. Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells

    Article • Clinical Cancer Research, March 2022, American Association for Cancer Research (AACR)

    Claudio Tripodo

  55. Histological and immunohistochemical findings in a fatal case of thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination

    Article • Pathology - Research and Practice, March 2022, Elsevier

    Claudio Tripodo

  56. A murine model of cerebral cavernous malformations with acute hemorrhage

    Article • iScience, March 2022, Elsevier

    Claudio Tripodo

  57. Immune pathway upregulation and lower genomic instability distinguish EBV-positive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

    Article • Haematologica, January 2022, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  58. Direct RNA Nanopore Sequencing of SARS-CoV-2 Extracted from Critical Material from Swabs

    Article • Life, January 2022, MDPI AG

    Prof Carmela Rita Balistreri, Claudio Tripodo

  59. DNA damage response at telomeres boosts the transcription of SARS‐CoV‐2 receptor ACE2 during aging

    Article • EMBO Reports, December 2021, EMBO

    Claudio Tripodo

  60. Tuning gut microbiota through a probiotic blend in gemcitabine‐treated pancreatic cancer xenografted mice

    Article • Clinical and Translational Medicine, November 2021, Wiley

    Claudio Tripodo

  61. PD‐1‐induced T cell exhaustion is controlled by a Drp1‐dependent mechanism

    Article • Molecular Oncology, October 2021, Wiley

    Claudio Tripodo

  62. A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer

    Article • Molecular Therapy, October 2021, Elsevier

    Claudio Tripodo

  63. A tribute to Juan Rosai

    Article • Pathologica, October 2021, Siapec Servizi Srl

    Claudio Tripodo

  64. HER2 Signaling and Breast Cancer Stem Cells: The Bridge behind HER2-Positive Breast Cancer Aggressiveness and Therapy Refractoriness

    Article • Cancers, September 2021, MDPI AG

    Claudio Tripodo

  65. Newly-Discovered Neural Features Expand the Pathobiological Knowledge of Blastic Plasmacytoid Dendritic Cell Neoplasm

    Article • Cancers, September 2021, MDPI AG

    Claudio Tripodo

  66. Compromised nuclear envelope integrity drives TREX1-dependent DNA damage and tumor cell invasion

    Article • Cell, September 2021, Elsevier

    Claudio Tripodo

  67. The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stress

    Article • Cell Reports, September 2021, Elsevier

    Claudio Tripodo

  68. Papulo‐purpuric dermatitis of childhood: a distinct PLEVA‐like eruption associated to SARS‐CoV‐2 infection. Clinical, histopathological and immunohistochemical study of 10 cases

    Article • Pediatric Dermatology, August 2021, Wiley

    Claudio Tripodo

  69. Burkitt lymphoma with a granulomatous reaction: an M1/Th1‐polarised microenvironment is associated with controlled growth and spontaneous regression

    Article • Histopathology, July 2021, Wiley

    Claudio Tripodo

  70. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer

    Article • Cancer Research, June 2021, American Association for Cancer Research (AACR)

    Claudio Tripodo

  71. DIGITAL SPATIAL PROFILING OF DIFFUSE LARGE B‐CELL LYMPHOMAS REVEALS STING AS AN IMMUNE‐RELATED DETERMINANT OF SURVIVAL AFTER R‐CHOP THERAPY

    Article • Hematological Oncology, June 2021, Wiley

    Claudio Tripodo

  72. Conceptual design of the main Ancillary Systems of the ITER Water Cooled Lithium Lead Test Blanket System

    Article • Fusion Engineering and Design, June 2021, Elsevier

    Claudio Tripodo

  73. SPARC regulation of PMN clearance protects from pristane-induced lupus and rheumatoid arthritis

    Article • iScience, June 2021, Elsevier

    Claudio Tripodo

  74. COVID-19 Vaccine and Death: Causality Algorithm According to the WHO Eligibility Diagnosis

    Article • Diagnostics, May 2021, MDPI AG

    Claudio Tripodo

  75. Neutrophil extracellular traps arm DC vaccination against NPM-mutant myeloproliferation

    Article • May 2021, Cold Spring Harbor Laboratory Press

    Claudio Tripodo

  76. Post-mortem findings in vaccine-induced thrombotic thombocytopenia

    Article • Haematologica, May 2021, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  77. CD40 Activity on Mesenchymal Cells Negatively Regulates OX40L to Maintain Bone Marrow Immune Homeostasis Under Stress Conditions

    Article • Frontiers in Immunology, May 2021, Frontiers

    Claudio Tripodo

  78. Epigenomic landscape of human colorectal cancer unveils an aberrant core of pan-cancer enhancers orchestrated by YAP/TAZ

    Article • Nature Communications, April 2021, Springer Science + Business Media

    Claudio Tripodo

  79. Myeloid and T-Cell Microenvironment Immune Features Identify Two Prognostic Sub-Groups in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms

    Article • Journal of Clinical Medicine, April 2021, MDPI AG

    Claudio Tripodo

  80. Myeloid cell heterogeneity in lung cancer: implication for immunotherapy

    Article • Medical Oncology, April 2021, Springer Science + Business Media

    Claudio Tripodo

  81. Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas

    Article • Cells, March 2021, MDPI AG

    Claudio Tripodo

  82. Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma

    Article • Frontiers in Immunology, March 2021, Frontiers

    Claudio Tripodo

  83. Definition of model-based control strategies for the Molten Salt Fast Reactor nuclear power plant

    Article • Nuclear Engineering and Design, March 2021, Elsevier

    Claudio Tripodo

  84. MYD88 L265P mutation and interleukin‐10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study

    Article • British Journal of Haematology, February 2021, Wiley

    Claudio Tripodo

  85. Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia

    Article • Journal for ImmunoTherapy of Cancer, February 2021, BMJ

    Claudio Tripodo, Dr Massimo Martino

  86. Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast Cancer

    Article • Cancer Research, January 2021, American Association for Cancer Research (AACR)

    Claudio Tripodo

  87. T-Cell Lymphoma Clonality by Copy Number Variation Analysis of T-Cell Receptor Genes

    Article • Cancers, January 2021, MDPI AG

    Claudio Tripodo

  88. Breast Cancer Organoids Model Patient-Specific Response to Drug Treatment

    Article • Cancers, December 2020, MDPI AG

    Claudio Tripodo

  89. Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfaces

    Article • EBioMedicine, November 2020, Elsevier

    Claudio Tripodo

  90. Mast cells crosstalk with B cells in the gut and sustain IgA response in the inflamed intestine

    Article • European Journal of Immunology, October 2020, Wiley

    Claudio Tripodo

  91. A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas

    Article • iScience, October 2020, Elsevier

    Claudio Tripodo

  92. SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta

    Article • EBioMedicine, September 2020, Elsevier

    Claudio Tripodo

  93. Abstract 1106: Cisplatin-induced activation of SDF-1/CXCR4 axis sustains lung cancer metastasis by promoting co-recruitment of metastasis initiating cells and inflammatory monocytes

    Article • Cancer Research, August 2020, American Association for Cancer Research (AACR)

    Claudio Tripodo

  94. SPARC regulation of PMN clearance protects from pristane induced lupus and rheumatoid arthritis

    Article • August 2020, Cold Spring Harbor Laboratory Press

    Claudio Tripodo

  95. Mutant p53 induces Golgi tubulo-vesiculation driving a prometastatic secretome

    Article • Nature Communications, August 2020, Springer Science + Business Media

    Claudio Tripodo

  96. Hematopoietic stem cell function in β-thalassemia is impaired and is rescued by targeting the bone marrow niche

    Article • Blood, July 2020, American Society of Hematology

    Claudio Tripodo

  97. IRSp53 controls plasma membrane shape and polarized transport at the nascent lumen in epithelial tubules

    Article • Nature Communications, July 2020, Springer Science + Business Media

    Claudio Tripodo

  98. Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs

    Article • Cancer Research, April 2020, American Association for Cancer Research (AACR)

    Claudio Tripodo

  99. Infiltrating Mast Cell–Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype

    Article • Cancer Research, March 2020, American Association for Cancer Research (AACR)

    Claudio Tripodo

  100. ATR expands embryonic stem cell fate potential in response to replication stress

    Article • eLife, March 2020, eLife

    Claudio Tripodo

  101. Heterogeneity Fair: Commentary to Menter and Tzankov “Lymphomas and Their Microenvironment: A Multifaceted Relationship”

    Article • Pathobiology, January 2020, Karger Publishers

    Claudio Tripodo

  102. Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue

    Article • Annals of Oncology, December 2019, Elsevier

    Claudio Tripodo

  103. Transcriptional profiles and stromal changes reveal bone marrow adaptation to early breast cancer in association with deregulated circulating microRNAs

    Article • Cancer Research, November 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  104. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson–Gilford Progeria Syndrome

    Article • Nature Communications, November 2019, Springer Science + Business Media

    Claudio Tripodo

  105. Hematopoietic Stem Cell Function in β-Thalassemia Is Impaired and Is Rescued By Targeting the Bone Marrow Niche

    Article • Blood, November 2019, American Society of Hematology

    Claudio Tripodo

  106. Correction to: A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit

    Article • Virchows Archiv, October 2019, Springer Science + Business Media

    Claudio Tripodo

  107. MA13.09 Cisplatin Sustains Lung Cancer Metastasis Through the Systemic Activation of SDF-1/CXCR4 Axis

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Claudio Tripodo

  108. OA14.06 Hyperprogressive Disease in Advanced Non–Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Claudio Tripodo

  109. Targeting CD34+ cells of the inflamed synovial endothelium by guided nanoparticles for the treatment of rheumatoid arthritis

    Article • Journal of Autoimmunity, September 2019, Elsevier

    Claudio Tripodo

  110. Neoadjuvant eribulin mesylate following anthracycline and taxane in triple negative breast cancer: Results from the HOPE study

    Article • PLOS One, August 2019, PLOS

    Claudio Tripodo

  111. A practical algorithmic approach to mature aggressive B cell lymphoma diagnosis in the double/triple hit era: selecting cases, matching clinical benefit

    Article • Virchows Archiv, August 2019, Springer Science + Business Media

    Claudio Tripodo

  112. Unjamming overcomes kinetic and proliferation arrest in terminally differentiated cells and promotes collective motility of carcinoma

    Article • Nature Materials, July 2019, Springer Science + Business Media

    Professor Roberto Cerbino, Claudio Tripodo

  113. Abstract 4959: The gut microbiota contributes to the effectiveness of HER2-targeted therapy

    Article • Cancer Research, July 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  114. SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities

    Article • Frontiers in Immunology, June 2019, Frontiers

    Claudio Tripodo

  115. Follicular dendritic cells display microvesicle-associated LMP1 in reactive germinal centers of EBV+ classic Hodgkin lymphoma

    Article • Virchows Archiv, June 2019, Springer Science + Business Media

    Claudio Tripodo

  116. IL‐10‐producing B cells are characterized by a specific methylation signature

    Article • European Journal of Immunology, May 2019, Wiley

    Claudio Tripodo

  117. The B‐cell receptor in control of tumor B‐cell fitness: Biology and clinical relevance

    Article • Immunological Reviews, March 2019, Wiley

    Claudio Tripodo

  118. Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity

    Article • Journal of Leukocyte Biology, February 2019, Wiley

    Claudio Tripodo

  119. Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells

    Article • Cancer Research, February 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  120. Antibody–Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non–small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade

    Article • Clinical Cancer Research, February 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  121. WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

    Article • Oncogene, January 2019, Springer Science + Business Media

    Claudio Tripodo

  122. Circulating mir‐320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk

    Article • International Journal of Cancer, January 2019, Wiley

    Claudio Tripodo

  123. Development of a control-oriented power plant simulator for the molten salt fast reactor

    Article • EPJ Nuclear Sciences & Technologies, January 2019, EDP Sciences

    Antonio Cammi, Claudio Tripodo

  124. Time for a “Plan B” in Peritoneal Metastatic Disease

    Article • Cancer Research, January 2019, American Association for Cancer Research (AACR)

    Claudio Tripodo

  125. Drp1 Controls Effective T Cell Immune-Surveillance by Regulating T Cell Migration, Proliferation, and cMyc-Dependent Metabolic Reprogramming

    Article • Cell Reports, December 2018, Elsevier

    Claudio Tripodo

  126. Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

    Article • Cytokine & Growth Factor Reviews, December 2018, Elsevier

    Claudio Tripodo

  127. Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue

    Article • Annals of Oncology, December 2018, Elsevier

    Claudio Tripodo

  128. Targeting a Specific Glycosylated Epitope of CD43 with a New Humanized Monoclonal Antibody for the Treatment of Pediatric and Adult T-Cell Acute Lymphoblastic Leukemia (T-ALL)

    Article • Blood, November 2018, American Society of Hematology

    Claudio Tripodo

  129. Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study

    Article • British Journal of Haematology, November 2018, Wiley

    Claudio Tripodo

  130. Blastic plasmacytoid dendritic cell neoplasm: genomics mark epigenetic dysregulation as a primary therapeutic target

    Article • Haematologica, October 2018, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  131. MA04.06 PD-1 Blockade Promotes Hyperprogressive Disease in NSCLC Through Macrophages Activation via Antibody-Fc/FcR Interaction

    Article • Journal of Thoracic Oncology, October 2018, Elsevier

    Claudio Tripodo

  132. Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer

    Article • Frontiers in Immunology, August 2018, Frontiers

    Claudio Tripodo

  133. Wnt3a Neutralization Enhances T-cell Responses through Indirect Mechanisms and Restrains Tumor Growth

    Article • Cancer Immunology Research, July 2018, American Association for Cancer Research (AACR)

    Claudio Tripodo

  134. Abstract 4981: Circulating mir-320 promotes immunosuppressive macrophages M2 phenotype associated with lung cancer progression

    Article • Cancer Research, July 2018, American Association for Cancer Research (AACR)

    Claudio Tripodo

  135. Abstract 2141: Stromal SPARC deficiency skews prostate cancer toward neuroendocrine differentiation

    Article • Cancer Research, July 2018, American Association for Cancer Research (AACR)

    Claudio Tripodo

  136. Abstract A24: Bone marrow hematopoietic adaptation as a sensor of early, pre-invasive, epithelial malignancy

    Article • Cancer Research, May 2018, American Association for Cancer Research (AACR)

    Claudio Tripodo

  137. Cross-Talk between Myeloid-Derived Suppressor Cells and Mast Cells Mediates Tumor-Specific Immunosuppression in Prostate Cancer

    Article • Cancer Immunology Research, March 2018, American Association for Cancer Research (AACR)

    Claudio Tripodo

  138. Microenvironmental regulation of the IL-23R/IL-23 axis overrides chronic lymphocytic leukemia indolence

    Article • Science Translational Medicine, February 2018, American Association for the Advancement of Science

    Claudio Tripodo, Daniela de Totero

  139. Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

    Article • Science Translational Medicine, January 2018, American Association for the Advancement of Science

    Claudio Tripodo

  140. Real-time detection of BRAF V600E mutation from archival hairy cell leukemia FFPE tissue by nanopore sequencing

    Article • Molecular Biology Reports, December 2017, Springer Science + Business Media

    Claudio Tripodo

  141. Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells

    Article • Cancer Letters, December 2017, Elsevier

    Claudio Tripodo

  142. IL-25 dampens the growth of human germinal center-derived B-cell non Hodgkin Lymphoma by curtailing neoangiogenesis

    Article • OncoImmunology, November 2017, Taylor & Francis

    Claudio Tripodo

  143. Complement Protein C1q Binds to Hyaluronic Acid in the Malignant Pleural Mesothelioma Microenvironment and Promotes Tumor Growth

    Article • Frontiers in Immunology, November 2017, Frontiers

    Claudio Tripodo

  144. Rheostatic Functions of Mast Cells in the Control of Innate and Adaptive Immune Responses

    Article • Trends in Immunology, September 2017, Elsevier

    Claudio Tripodo

  145. Distribution and function of the complement protein C1q in malignant pleural mesothelioma microenvironment

    Article • Molecular Immunology, September 2017, Elsevier

    Claudio Tripodo

  146. Neoadjuvant eribulin following anthracycline and taxane in triple negative breast cancer (HOPE): A multicenter, two stage, phase II trial

    Article • Annals of Oncology, September 2017, Elsevier

    Claudio Tripodo

  147. Antibody-mediated blockade of JMJD6 interaction with collagen I exerts antifibrotic and antimetastatic activities

    Article • The FASEB Journal, August 2017, Federation of American Societies For Experimental Biology (FASEB)

    SILVIA MIOTTI, Claudio Tripodo

  148. The good and bad of targeting cancer-associated extracellular matrix

    Article • Current Opinion in Pharmacology, August 2017, Elsevier

    Claudio Tripodo

  149. Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat

    Article • Hematological Oncology, July 2017, Wiley

    Claudio Tripodo

  150. Abstract 5437: miR-302b as adjuvant therapeutic tool to improve chemotherapy efficacy in human triple-negative breast cancer

    Article • Cancer Research, July 2017, American Association for Cancer Research (AACR)

    Claudio Tripodo

  151. Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer

    Article • OncoImmunology, June 2017, Taylor & Francis

    Claudio Tripodo

  152. Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors

    Article • Clinical Cancer Research, June 2017, American Association for Cancer Research (AACR)

    Claudio Tripodo

  153. Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal Remodeling

    Article • Cancer Research, May 2017, American Association for Cancer Research (AACR)

    Claudio Tripodo

  154. IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia

    Article • Apmis, May 2017, Wiley

    Dr Ottavio Piccin, Donato Zipeto, Claudio Tripodo

  155. Common extracellular matrix regulation of myeloid cell activity in the bone marrow and tumor microenvironments

    Article • Medical Oncology, May 2017, Springer Science + Business Media

    Claudio Tripodo

  156. Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10 + phenotype

    Article • Clinical Immunology, May 2017, Elsevier

    Claudio Tripodo

  157. Mast cells are associated with the onset and progression of celiac disease

    Article • Journal of Allergy and Clinical Immunology, April 2017, Elsevier

    Claudio Tripodo

  158. Distinctive Histogenesis and Immunological Microenvironment Based on Transcriptional Profiles of Follicular Dendritic Cell Sarcomas

    Article • Molecular Cancer Research, January 2017, American Association for Cancer Research (AACR)

    Claudio Tripodo

  159. P2.01-017 Circulating miRNAs in Lung Cancer Are Associated to Pro-Tumorigenic and Immunosuppressive Microenvironment

    Article • Journal of Thoracic Oncology, January 2017, Elsevier

    Claudio Tripodo

  160. Imatinib Spares cKit-Expressing Prostate Neuroendocrine Tumors, whereas Kills Seminal Vesicle Epithelial–Stromal Tumors by Targeting PDGFR-β

    Article • Molecular Cancer Therapeutics, December 2016, American Association for Cancer Research (AACR)

    Claudio Tripodo

  161. Arginase 1 Is a Marker of Myeloid-Mediated Immunosuppression with Prognostic Meaning in Classic Hodgkin Lymphoma

    Article • Blood, December 2016, American Society of Hematology

    Claudio Tripodo

  162. The combined role of biomarkers and interim PET scan in prediction of treatment outcome in classical Hodgkin's lymphoma: a retrospective, European, multicentre cohort study

    Article • The Lancet Haematology, October 2016, Elsevier

    Claudio Tripodo

  163. The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma

    Article • Oncotarget, September 2016, Impact Journals, LLC

    Claudio Tripodo

  164. Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity

    Article • Cell Reports, September 2016, Elsevier

    Claudio Tripodo

  165. Abstract 3289: Microenvironment modulation and enhancement of cytotoxic therapy by the heparanase inhibitor Roneparstat against human B-non Hodgkin lymphomas

    Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

    Claudio Tripodo

  166. miR-9 and miR-200 Regulate PDGFRβ-Mediated Endothelial Differentiation of Tumor Cells in Triple-Negative Breast Cancer

    Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

    Claudio Tripodo

  167. FRI0030 Anti-TNF-α Antibody Targeted To Inflamed Synovial Tissue for The Treatment of Rheumatoid Arthritis

    Article • Annals of the Rheumatic Diseases, June 2016, Elsevier

    Claudio Tripodo

  168. Abstract A18: miR-9 and miR-200 regulate PDGFRβ-mediated endothelial differentiation of neoplastic cells in triple-negative breast cancer

    Article • Cancer Research, March 2016, American Association for Cancer Research (AACR)

    Claudio Tripodo

  169. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

    Article • Journal of Hepatology, March 2016, Elsevier

    Claudio Tripodo

  170. C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation

    Article • Nature Communications, February 2016, Springer Science + Business Media

    Claudio Tripodo

  171. Abstract B157: OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer

    Article • Cancer Immunology Research, January 2016, American Association for Cancer Research (AACR)

    Dr Fabio Martinelli, Claudio Tripodo

  172. MEF2C and SOCS2 in stemness regulation

    Article • Oncoscience, December 2015, Impact Journals, LLC

    Claudio Tripodo

  173. Genetic deletion of osteopontin in TRAMP mice skews prostate carcinogenesis from adenocarcinoma to aggressive human-like neuroendocrine cancers

    Article • Oncotarget, December 2015, Impact Journals, LLC

    Claudio Tripodo

  174. A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles

    Article • Nano Research, December 2015, Tsinghua University Press

    Claudio Tripodo

  175. Alteration of HSC Functions in Thalassemia

    Article • Blood, December 2015, American Society of Hematology

    Claudio Tripodo

  176. Microenvironment Regulation of IL23R/IL-23 Axis Drives Chronic Lymphocytic Leukemia (CLL) Progression

    Article • Blood, December 2015, American Society of Hematology

    Claudio Tripodo

  177. A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome

    Article • Oncoscience, November 2015, Impact Journals, LLC

    Claudio Tripodo

  178. AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression

    Article • Oncogene, October 2015, Springer Science + Business Media

    Claudio Tripodo

  179. Poly(I:C) and CpG-ODN combined aerosolization to treat lung metastases and counter the immunosuppressive microenvironment

    Article • OncoImmunology, August 2015, Taylor & Francis

    Claudio Tripodo

  180. Interleukin-17A promotes the growth of human germinal center derived non-Hodgkin B cell lymphoma

    Article • OncoImmunology, August 2015, Taylor & Francis

    Claudio Tripodo

  181. RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis

    Article • Cancer Cell, August 2015, Elsevier

    Claudio Tripodo

  182. Abstract 4054: Mast cells contribute to T cell tolerance against prostate cancer- associated antigens favoring tumor growth

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Claudio Tripodo

  183. Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas

    Article • Oncotarget, July 2015, Impact Journals, LLC

    Claudio Tripodo

  184. Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth

    Article • Cancer Research, July 2015, American Association for Cancer Research (AACR)

    Claudio Tripodo

  185. Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: a Fondazione Italiana Linfomi phase II study

    Article • Leukemia & Lymphoma, July 2015, Taylor & Francis

    Claudio Tripodo

  186. Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies

    Article • International Journal of Nanomedicine, June 2015, Dove Medical Press

    Claudio Tripodo

  187. OX40 expression in tumor-associated Tregs as a potential prognostic biomarker and immunotherapeutic target in ovarian cancer.

    Article • Journal of Clinical Oncology, May 2015, American Society of Clinical Oncology (ASCO)

    Dr Fabio Martinelli, Claudio Tripodo

  188. “Cancer Bio-Immunotherapy in Siena”: Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9–11, 2014

    Article • Medical Oncology, May 2015, Springer Science + Business Media

    Claudio Tripodo

  189. SCD5-induced oleic acid production reduces melanoma malignancy by intracellular retention of SPARC and cathepsin B

    Article • The Journal of Pathology, April 2015, Wiley

    Claudio Tripodo

  190. SOCS2 Controls Proliferation and Stemness of Hematopoietic Cells under Stress Conditions and Its Deregulation Marks Unfavorable Acute Leukemias

    Article • Cancer Research, April 2015, American Association for Cancer Research (AACR)

    Claudio Tripodo

  191. HSPH1 inhibition downregulates Bcl-6 and c-Myc and hampers the growth of human aggressive B-cell non-Hodgkin lymphoma

    Article • Blood, March 2015, American Society of Hematology

    Claudio Tripodo

  192. The ins and outs of osteopontin

    Article • OncoImmunology, March 2015, Taylor & Francis

    Claudio Tripodo

  193. IFI16Expression Is Related to Selected Transcription Factors during B-Cell Differentiation

    Article • Journal of Immunology Research, January 2015, Hindawi Publishing Corporation

    Professor Marco De Andrea, Claudio Tripodo

  194. The Hepatic Expression of Vitamin D Receptor Is Inversely Associated With the Severity of Liver Damage in Genotype 1 Chronic Hepatitis C Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2015, Endocrine Society

    Claudio Tripodo

  195. Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post-transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus

    Article • Frontiers in Microbiology, December 2014, Frontiers

    Claudio Tripodo

  196. Human OX40 tunes the function of regulatory T cells in tumor and nontumor areas of hepatitis C virus–infected liver tissue

    Article • Hepatology, November 2014, Wolters Kluwer Health

    Professor Stefania Brozzetti, Claudio Tripodo

  197. Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified

    Article • Blood Cancer Journal, November 2014, Springer Science + Business Media

    Claudio Tripodo

  198. Mast Cells Boost Myeloid-Derived Suppressor Cell Activity and Contribute to the Development of Tumor-Favoring Microenvironment

    Article • Cancer Immunology Research, October 2014, American Association for Cancer Research (AACR)

    Claudio Tripodo

  199. Abstract A42: miR34a: A valuable indicator of differential outcome of Ewing sarcoma patients with complex functions

    Article • October 2014, American Association for Cancer Research (AACR)

    Claudio Tripodo

  200. The interleukin (IL)-31/IL-31R axis contributes to tumor growth in human follicular lymphoma

    Article • Leukemia, October 2014, Springer Science + Business Media

    Claudio Tripodo, Maria Valeria Corrias

  201. Abstract 2362: Identification and characterization of pathogenetic pathways and potential therapeutic targets in tumors derived from histiocytes and follicular dendritic cells

    Article • September 2014, American Association for Cancer Research (AACR)

    Claudio Tripodo

  202. Mast Cells Control the Expansion and Differentiation of IL-10–Competent B Cells

    Article • The Journal of Immunology, September 2014, The American Association of Immunologists

    Claudio Tripodo

  203. Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

    Article • Blood, September 2014, American Society of Hematology

    Claudio Tripodo

  204. Osteopontin Shapes Immunosuppression in the Metastatic Niche

    Article • Cancer Research, July 2014, American Association for Cancer Research (AACR)

    Claudio Tripodo

  205. Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression

    Article • Annals of Oncology, July 2014, Oxford University Press (OUP)

    Claudio Tripodo

  206. Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

    Article • Leukemia, June 2014, Springer Science + Business Media

    Claudio Tripodo

  207. Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies

    Article • OncoImmunology, June 2014, Taylor & Francis

    Claudio Tripodo

  208. P816 MERTK rs4374383 AA GENOTYPE IS ASSOCIATED WITH A LOWER PREVALENCE OF SEVERE HEPATIC STEATOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE

    Article • Journal of Hepatology, April 2014, Elsevier

    Claudio Tripodo

  209. PDGFRβ and FGFR2 mediate endothelial cell differentiation capability of triple negative breast carcinoma cells

    Article • Molecular Oncology, March 2014, Wiley

    Claudio Tripodo

  210. Bone marrow stroma CD40 expression correlates with inflammatory mast cell infiltration and disease progression in splenic marginal zone lymphoma

    Article • Blood, March 2014, American Society of Hematology

    Claudio Tripodo

  211. C1q as a unique player in angiogenesis with therapeutic implication in wound healing

    Article • Proceedings of the National Academy of Sciences, March 2014, Proceedings of the National Academy of Sciences

    Claudio Tripodo

  212. Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages

    Article • Haematologica, February 2014, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo, Daniela de Totero

  213. Molecular profiling of blastic plasmacytoid dendritic cell neoplasm reveals a unique pattern and suggests selective sensitivity to NF-kB pathway inhibition

    Article • Leukemia, February 2014, Springer Science + Business Media

    Claudio Tripodo

  214. MERTK rs4374383 AA genotype is associated with a lower prevalence of severe hepatic steatosis in non-alcoholic fatty liver disease

    Article • Digestive and Liver Disease, February 2014, Elsevier

    Claudio Tripodo

  215. Platelet-derived growth factor alpha mediates the proliferation of peripheral T-cell lymphoma cells via an autocrine regulatory pathway

    Article • Leukemia, January 2014, Springer Science + Business Media

    Claudio Tripodo

  216. The Role of Inflammation in Lymphoma

    Article • January 2014, Springer Science + Business Media

    Claudio Tripodo

  217. RNA recognition by human TLR8 can lead to autoimmune inflammation

    Article • Journal of Experimental Medicine, November 2013, Rockefeller University Press

    Claudio Tripodo

  218. Reproducibility of the WHO histological criteria for the diagnosis of Philadelphia chromosome-negative myeloproliferative neoplasms

    Article • Modern Pathology, November 2013, Springer Science + Business Media

    Claudio Tripodo

  219. Defective Stromal Remodeling and Neutrophil Extracellular Traps in Lymphoid Tissues Favor the Transition from Autoimmunity to Lymphoma

    Article • Cancer Discovery, November 2013, American Association for Cancer Research (AACR)

    Claudio Tripodo

  220. Ultrasound-guided intra-tumor injection of combined immunotherapy cures mice from orthotopic prostate cancer

    Article • Medical Oncology, October 2013, Springer Science + Business Media

    Claudio Tripodo

  221. New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles

    Article • PLOS One, September 2013, PLOS

    Claudio Tripodo

  222. Two Patients With History of STEC-HUS, Posttransplant Recurrence and Complement Gene Mutations

    Article • Arabian archaeology and epigraphy, June 2013, Wiley

    Claudio Tripodo

  223. Response to Villanacci et al.

    Article • The American Journal of Gastroenterology, April 2013, Wolters Kluwer Health

    Claudio Tripodo

  224. The abrogation of the HOXB7/PBX2 complex induces apoptosis in melanoma through the miR‐221&222‐c‐FOS pathway

    Article • International Journal of Cancer, March 2013, Wiley

    Claudio Tripodo

  225. The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation

    Article • Haematologica, January 2013, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  226. Class IIa HDACs repressive activities on MEF2-depedent transcription are associated with poor prognosis of ER+ breast tumors

    Article • The FASEB Journal, November 2012, Federation of American Societies For Experimental Biology (FASEB)

    Claudio Tripodo

  227. New Therapeutic Approach for the Treatment of B-Cell Disorders Using Chlorambucil/Hydroxychloroquine-Loaded AntiCD20 Nanoparticles

    Article • Blood, November 2012, American Society of Hematology

    Claudio Tripodo

  228. C1q secreted in the tumour microenvironment promotes tumour growth in the absence of complement activation

    Article • Immunobiology, November 2012, Elsevier

    Claudio Tripodo

  229. Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansion

    Article • Blood, October 2012, American Society of Hematology

    Claudio Tripodo

  230. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity

    Article • Blood, October 2012, American Society of Hematology

    Claudio Tripodo

  231. A complex case of fatal calciphylaxis in a female patient with hyperparathyroidism secondary to end stage renal disease of graft and coexistence of haemolytic uremic syndrome

    Article • Biomedical Papers, September 2012, Palacky University Olomouc

    Dr. Vincenzo D Palumbo, Claudio Tripodo

  232. Sistemic calciphylaxis and thrombotic microangiopathy in a kidney transplant patient: Two mixing fatal syndromes?

    Article • Medical Hypotheses, July 2012, Elsevier

    Claudio Tripodo

  233. 243 Triple Negative Breast Carcinoma Cells Directly Contribute to Tumor Vasculature by Endothelial Differentiation Capability

    Article • European Journal of Cancer, July 2012, Elsevier

    Claudio Tripodo

  234. The Aryl Hydrocarbon Receptor Modulates Acute and Late Mast Cell Responses

    Article • The Journal of Immunology, May 2012, The American Association of Immunologists

    Claudio Tripodo

  235. Abstract 2997: Peripheral T-cell lymphomas not otherwise specified correspond to distinct mature T-cell populations basing on the global gene expression profile

    Article • Cancer Research, April 2012, American Association for Cancer Research (AACR)

    Claudio Tripodo

  236. Microenvironment-Centred Dynamics in Aggressive B-Cell Lymphomas

    Article • Advances in Hematology, January 2012, Hindawi Publishing Corporation

    Claudio Tripodo

  237. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia

    Article • Blood, December 2011, American Society of Hematology

    Claudio Tripodo

  238. CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death

    Article • Blood, December 2011, American Society of Hematology

    Claudio Tripodo

  239. SPARC Oppositely Regulates Inflammation and Fibrosis in Bleomycin-Induced Lung Damage

    Article • American Journal Of Pathology, December 2011, Elsevier

    Claudio Tripodo

  240. The matricellular protein SPARC supports follicular dendritic cell networking toward Th17 responses

    Article • Journal of Autoimmunity, December 2011, Elsevier

    Claudio Tripodo

  241. CD73-Generated Extracellular Adenosine Creates Microenvironmental Conditions Favoring Growth and Survival of Chronic Lymphocytic Leukemia Cells

    Article • Blood, November 2011, American Society of Hematology

    Claudio Tripodo

  242. SNPs Array Karyotyping Reveals a Novel Recurrent 20p13 Amplification in Primary Myelofibrosis

    Article • PLOS One, November 2011, PLOS

    Claudio Tripodo

  243. Serological identification of HSP105 as a novel non-Hodgkin lymphoma therapeutic target

    Article • Blood, October 2011, American Society of Hematology

    Claudio Tripodo

  244. MMP-13 stimulates osteoclast differentiation and activation in tumour breast bone metastases

    Article • October 2011, Springer Science + Business Media

    PhD Paola Spessotto, Claudio Tripodo

  245. Mast Cell Targeting Hampers Prostate Adenocarcinoma Development but Promotes the Occurrence of Highly Malignant Neuroendocrine Cancers

    Article • Cancer Research, September 2011, American Association for Cancer Research (AACR)

    Claudio Tripodo

  246. Peripheral T-cell lymphoma classification: the matter of cellular derivation

    Article • Expert Review of Hematology, August 2011, Taylor & Francis

    Claudio Tripodo

  247. C1q induces in vivo angiogenesis and promotes wound healing

    Article • Molecular Immunology, August 2011, Elsevier

    Claudio Tripodo

  248. Preeclampsia is associated with defective production of C1q by invasive trophoblast

    Article • Molecular Immunology, August 2011, Elsevier

    Claudio Tripodo, PhD Paola Spessotto

  249. New treatment of multiple mieloma and anaplastic T cell lymphoma using C-fixing anti-CD162 antibodies

    Article • Molecular Immunology, August 2011, Elsevier

    Claudio Tripodo

  250. Technical Advance: Soluble OX40 molecule mimics regulatory T cell modulatory activity on FcɛRI-dependent mast cell degranulation

    Article • Journal of Leukocyte Biology, June 2011, Wiley

    Claudio Tripodo

  251. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment

    Article • Leukemia, May 2011, Springer Science + Business Media

    Claudio Tripodo

  252. High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis

    Article • Digestive and Liver Disease, May 2011, Elsevier

    Claudio Tripodo

  253. Gene expression analysis uncovers similarity and differences among Burkitt lymphoma subtypes

    Article • Blood, March 2011, American Society of Hematology

    Claudio Tripodo

  254. The bone marrow stroma in hematological neoplasms—a guilty bystander

    Article • Nature Reviews Clinical Oncology, March 2011, Springer Science + Business Media

    Claudio Tripodo

  255. How I diagnose and treat splenic lymphomas

    Article • Blood, March 2011, American Society of Hematology

    Claudio Tripodo

  256. 480 FOLLICULAR HELPER T-CELLS POPULATE THE INTRAHEPATIC INFILTRATES OF HCV GENOTYPE-1 CHRONICALLY INFECTED PATIENTS AND PREDICT THE ACHIEVEMENT OF VIROLOGICAL RESPONSE FOLLOWING IFN-BASED TREATMENT

    Article • Journal of Hepatology, March 2011, Elsevier

    Claudio Tripodo

  257. Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient KitW-sh/W-sh mice

    Article • Laboratory Investigation, February 2011, Springer Science + Business Media

    Claudio Tripodo

  258. T-18 Liver follicular helper T-cells in chronic hepatitis C

    Article • Digestive and Liver Disease, February 2011, Elsevier

    Claudio Tripodo

  259. Liver follicular helper T-cells predict the achievement of virological response following interferon-based treatment in HCV-infected patients

    Article • Antiviral Therapy, January 2011, International Medical Press

    Claudio Tripodo

  260. Pathobiology of Hodgkin Lymphoma

    Article • Advances in Hematology, January 2011, Hindawi Publishing Corporation

    Claudio Tripodo

  261. Posters of XXXVIII Annual ESAO & IV Biennial IFAO Congress, 9-12 October 2011, Porto, Portugal

    Article • The International Journal of Artificial Organs, January 2011, SAGE Publications

    Claudio Tripodo

  262. A variant of the LRP4 gene affects the risk of chronic lymphocytic leukaemia transformation to Richter syndrome

    Article • British Journal of Haematology, December 2010, Wiley

    Claudio Tripodo

  263. Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

    Article • Blood, November 2010, American Society of Hematology

    Dr Francesco Bertoni, Claudio Tripodo, Prof. Emanuele Zucca

  264. Autoimmune skin inflammation is dependent on plasmacytoid dendritic cell activation by nucleic acids via TLR7 and TLR9

    Article • Journal of Experimental Medicine, November 2010, Rockefeller University Press

    Claudio Tripodo

  265. Gene Expression Analysis Uncovers Similarity and Differences Among Burkitt Lymphoma Subtypes

    Article • Blood, November 2010, American Society of Hematology

    Claudio Tripodo

  266. Tumor-intrinsic and -extrinsic roles of c-Kit: mast cells as the primary off-target of tyrosine kinase inhibitors

    Article • Oncogene, November 2010, Springer Science + Business Media

    Claudio Tripodo

  267. Exploratory Study on the Effects of Biodegradable Nanoparticles with Drugs on Malignant B Cells and on a Human/Mouse Model of Burkitt Lymphoma

    Article • Current Clinical Pharmacology, November 2010, Bentham Science Publishers

    Claudio Tripodo

  268. Oncogene-Driven Intrinsic Inflammation Induces Leukocyte Production of Tumor Necrosis Factor That Critically Contributes to Mammary Carcinogenesis

    Article • Cancer Research, October 2010, American Association for Cancer Research (AACR)

    Claudio Tripodo

  269. Mesenchymal stem cells display hepato-protective activity in lymphoma bearing xenografts

    Article • Investigational New Drugs, September 2010, Springer Science + Business Media

    Claudio Tripodo

  270. An Alternative Role of C1q in Cell Migration and Tissue Remodeling: Contribution to Trophoblast Invasion and Placental Development

    Article • The Journal of Immunology, September 2010, The American Association of Immunologists

    PhD Paola Spessotto, Claudio Tripodo

  271. Mast Cells and Th17 Cells Contribute to the Lymphoma-Associated Pro-Inflammatory Microenvironment of Angioimmunoblastic T-Cell Lymphoma

    Article • American Journal Of Pathology, August 2010, Elsevier

    Claudio Tripodo

  272. Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia

    Article • Blood, July 2010, American Society of Hematology

    Claudio Tripodo

  273. A non-redundant role for OX40 in the competitive fitness of Treg in response to IL-2

    Article • European Journal of Immunology, July 2010, Wiley

    Claudio Tripodo

  274. Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts

    Article • PLOS One, June 2010, PLOS

    Claudio Tripodo

  275. Mast cells enhance proliferation of B lymphocytes and drive their differentiation toward IgA-secreting plasma cells

    Article • Blood, April 2010, American Society of Hematology

    Claudio Tripodo

  276. Humoral immunotherapy of multiple myeloma: perspectives and perplexities

    Article • Expert Opinion on Biological Therapy, April 2010, Informa Healthcare

    Claudio Tripodo

  277. Monocytes/macrophages but not T lymphocytes are the major targets of the CCL3/CCL4 chemokines produced by CD38+CD49d+chronic lymphocytic leukaemia cells

    Article • British Journal of Haematology, March 2010, Wiley

    Claudio Tripodo

  278. Exploring a regulatory role for mast cells: ‘MCregs’?

    Article • Trends in Immunology, March 2010, Elsevier

    Claudio Tripodo

  279. F.N.32 LIVER EXPRESSION OF RBP4 CORRELATES WITH LIVER DAMAGE IN CHRONIC HEPATITIS C AND IN NONALCOHOLIC FATTY LIVER DISEASE

    Article • Digestive and Liver Disease, February 2010, Elsevier

    Claudio Tripodo

  280. T Cell Large Granular Lymphocytic Leukemia in Association with Sjögren’s Syndrome

    Article • Acta Haematologica, January 2010, Karger Publishers

    Claudio Tripodo

  281. Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C

    Article • Hepatology, December 2009, Wiley

    Claudio Tripodo

  282. Gamma-delta T-cell lymphomas

    Article • Nature Reviews Clinical Oncology, November 2009, Springer Science + Business Media

    Claudio Tripodo

  283. Mast cells counteract regulatory T-cell suppression through interleukin-6 and OX40/OX40L axis toward Th17-cell differentiation

    Article • Blood, September 2009, American Society of Hematology

    Claudio Tripodo

  284. Phenotype characterization of the anti-inflammatory behavior of decidual endothelial cells

    Article • Journal of Reproductive Immunology, September 2009, Elsevier

    Claudio Tripodo

  285. P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)

    Article • Current Cancer Drug Targets, August 2009, Bentham Science Publishers

    Claudio Tripodo

  286. Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection

    Article • Journal of Viral Hepatitis, June 2009, Wiley

    Claudio Tripodo

  287. CD38/CD31, the CCL3 and CCL4 Chemokines, and CD49d/Vascular Cell Adhesion Molecule-1 Are Interchained by Sequential Events Sustaining Chronic Lymphocytic Leukemia Cell Survival

    Article • Cancer Research, April 2009, American Association for Cancer Research (AACR)

    Claudio Tripodo

  288. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function

    Article • Blood, April 2009, American Society of Hematology

    Claudio Tripodo

  289. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis

    Article • Arthritis & Rheumatism, April 2009, Wiley

    Claudio Tripodo

  290. Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial

    Article • Clinical Lymphoma & Myeloma, April 2009, Elsevier

    Claudio Tripodo

  291. Different immunophenotypical apoptotic profiles characterise megakaryocytes of essential thrombocythaemia and primary myelofibrosis

    Article • Journal of Clinical Pathology, March 2009, BMJ

    Claudio Tripodo

  292. CD146+ bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis

    Article • Haematologica, January 2009, Ferrata Storti Foundation (Haematologica)

    Claudio Tripodo

  293. Progressive visceral leishmaniasis misdiagnosed as cirrhosis of the liver: a case report

    Article • Journal of Medical Case Reports, January 2009, Springer Science + Business Media

    Claudio Tripodo

  294. Selection and Characterization of a Novel Agonistic Human Recombinant Anti-Trail-R2 Minibody with Antileukemic Activity

    Article • International Journal of Immunopathology and Pharmacology, January 2009, SAGE Publications

    Claudio Tripodo

  295. An automated image analysis methodology for classifying megakaryocytes in chronic myeloproliferative disorders

    Article • Medical Image Analysis, December 2008, Elsevier

    Claudio Tripodo

  296. Angioimmunoblastic T-cell lymphoma

    Article • Critical Reviews in Oncology/Hematology, December 2008, Elsevier

    Claudio Tripodo

  297. CD4+CD25+ Regulatory T Cells Suppress Mast Cell Degranulation and Allergic Responses through OX40-OX40L Interaction

    Article • Immunity, November 2008, Elsevier

    Claudio Tripodo

  298. In Vivo Biodistribution and Lifetime Analysis of Cy5.5-Conjugated Rituximab in Mice Bearing Lymphoid Tumor Xenograft Using Time-Domain Near-Infrared Optical Imaging

    Article • Molecular Imaging, November 2008, SAGE Publications

    Claudio Tripodo

  299. The soluble terminal complement complex (SC5b-9) up-regulates osteoprotegerin expression and release by endothelial cells: implications in rheumatoid arthritis

    Article • Rheumatology, October 2008, Oxford University Press (OUP)

    Claudio Tripodo

  300. Carbamazepine Transbuccal Delivery: The Histo-Morphological Features of Reconstituted Human Oral Epithelium and Buccal Porcine Mucosae in the Transmucosal Permeation

    Article • International Journal of Immunopathology and Pharmacology, October 2008, SAGE Publications

    Prof Lorenzo Lo Muzio, Claudio Tripodo

  301. Development of a human-SCID lymphoma as a model to evaluate the therapeutic effect of Rituximab

    Article • Molecular Immunology, October 2008, Elsevier

    Claudio Tripodo

  302. Is local complement activation involved in renal damage in patients with atypical haemolytic uraemic syndrome?

    Article • Molecular Immunology, October 2008, Elsevier

    Claudio Tripodo

  303. An Update on the Xenograft and Mouse Models Suitable for Investigating New Therapeutic Compounds for the Treatment of B-Cell Malignancies

    Article • Current Pharmaceutical Design, July 2008, Bentham Science Publishers

    Claudio Tripodo

  304. Decidual endothelial cells express surface-bound C1q as a molecular bridge between endovascular trophoblast and decidual endothelium

    Article • Molecular Immunology, May 2008, Elsevier

    Claudio Tripodo

  305. Serum BLyS/BAFF levels in acute hepatitis C predict clinical outcome

    Article • Digestive and Liver Disease, May 2008, Elsevier

    Claudio Tripodo

  306. Histological Features and ki-67 Index in Cervical Atypical Lesions

    Article • American Journal of Infectious Diseases, March 2008, Science Publications

    Claudio Tripodo

  307. In vivo Targeting of Human Neutralizing Antibodies against CD55 and CD59 to Lymphoma Cells Increases the Antitumor Activity of Rituximab

    Article • Cancer Research, November 2007, American Association for Cancer Research (AACR)

    Claudio Tripodo

  308. Predictive role of histological features and Ki67 pattern on high-risk HPV presence in atypical cervical lesions

    Article • Histopathology, November 2007, Wiley

    Claudio Tripodo

  309. Use of intrapleural bortezomib in myelomatous pleural effusion

    Article • British Journal of Haematology, November 2007, Wiley

    Claudio Tripodo

  310. Colon Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by Production of Interleukin-4

    Article • Cell Stem Cell, October 2007, Elsevier

    Dr ANNA BARBARA DI STEFANO, Claudio Tripodo

  311. Release of naltrexone on buccal mucosa: Permeation studies, histological aspects and matrix system design

    Article • European Journal of Pharmaceutics and Biopharmaceutics, September 2007, Elsevier

    Claudio Tripodo

  312. C1q is involved in human trophoblast invasion

    Article • Molecular Immunology, September 2007, Elsevier

    Claudio Tripodo

  313. C1q Production by Bone Marrow Stromal Cells

    Article • Scandinavian Journal of Immunology, March 2007, Wiley

    Claudio Tripodo

  314. Associations between Notch-2, Akt-1 and HER2/neu Expression in Invasive Human Breast Cancer: A Tissue Microarray Immunophenotypic Analysis on 98 Patients

    Article • Pathobiology, January 2007, Karger Publishers

    Claudio Tripodo

  315. Neutralizing human antibodies against CD55 and CD59 targeted to lymphoma cells in vivo potentiate the therapeutic effect of Rituximab

    Article • Molecular Immunology, January 2007, Elsevier

    Claudio Tripodo

  316. Constant Detection of Cyclooxygenase 2 in Terminal Stages of Myeloid Maturation

    Article • Acta Haematologica, November 2006, Karger Publishers

    Claudio Tripodo

  317. Thyroid Sarcoidosis as a Unique Localization

    Article • Thyroid, November 2006, Mary Ann Liebert Inc

    Claudio Tripodo

  318. Reply to Pich et al.: intrasinusoidal bone marrow infiltration and splenic marginal zone lymphoma: a quantitative study

    Article • European Journal Of Haematology, October 2006, Wiley

    Claudio Tripodo

  319. Small Bowel Angiodysplasia Associated with von Willebrand's Disease: Report of a Case

    Article • Surgery Today, June 2006, Springer Science + Business Media

    Claudio Tripodo

  320. Splenic marginal zone lymphoma: a prognostic model for clinical use

    Article • Blood, June 2006, American Society of Hematology

    Claudio Tripodo

  321. Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma

    Article • European Journal Of Haematology, February 2006, Wiley

    Claudio Tripodo

  322. Immunophenotypic profile and role of adhesion molecules in splenic marginal zone lymphoma with bone marrow involvement

    Article • Leukemia & Lymphoma, January 2006, Taylor & Francis

    Claudio Tripodo

  323. Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes

    Article • European Journal Of Haematology, August 2005, Wiley

    Claudio Tripodo

  324. Identification of CD162 in plasma-cell dyscrasia

    Article • The Lancet Oncology, August 2005, Elsevier

    Claudio Tripodo

  325. 16. Clinical-Pathological Correlations

    Article • Annals of Oncology, June 2005, Elsevier

    Claudio Tripodo

  326. Correlation between expression of cyclooxygenase-2 and the presence of inflammatory cells in human primary hepatocellular carcinoma: Possible role in tumor promotion and angiogenesis

    Article • World Journal of Gastroenterology, January 2005, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Claudio Tripodo

  327. Splenic marginal zone lymphoma with or without villous lymphocytes

    Article • Cancer, October 2004, Wiley

    Claudio Tripodo

  328. Re: ?Splenic marginal zone B-cell lymphoma associated with primary Sj�gren?s syndrome?

    Article • Clinical Rheumatology, September 2004, Springer Science + Business Media

    Claudio Tripodo

  329. Bone marrow biopsy in Hodgkin's lymphoma

    Article • European Journal Of Haematology, July 2004, Wiley

    Claudio Tripodo

  330. Long-lasting remission of primary hepatic lymphoma and hepatitis C virus infection achieved by the alpha-interferon treatment

    Article • The Hematology Journal, January 2004, Springer Science + Business Media

    Claudio Tripodo

  331. Primary T-cell rich B-cell lymphoma of the penis: a first case

    Article • BJU International, May 2003, Wiley

    Claudio Tripodo